LEUVEN, Belgium, September 19 /PRNewswire/ -- Kingfisher Healthcare (KFH) announces the launch of KFH Energy, a product to alleviate fatigue and pain, two common problems associated with chronic diseases such as post polio syndrome, fibromyalgia and multiple sclerosis. KFH Energy is a patented, high-tech medical device for home use.
The KFH Energy utilizes Bio-Electric Stimulation Therapy (BEST) to deliver extremely low currents to the body. BEST works by enhancing the physiological processes at cellular level, documented effects include:
- an increase in ATP production, the molecule that delivers energy to all cells in the body
- increased synthesis of proteins, the building blocks of the body
The founder and CEO of KFH, Dr Henk Snyman, said: "We are very proud to introduce such a superior and safe solution to the many people suffering from fatigue, pain and lack of stamina. We are dedicated to continuing research and are exploring further applications in ongoing clinical trials."
The 1st clinical trial showed excellent results in post polio patients, and KFH has decided to support further research into the puzzling deterioration that many polio patients experience later in life. Dr Snyman indicated: "We are therefore very pleased to announce the creation of an annual Marianne Liefers Post polio Research Award, to the value of CAD$5.000. An independent panel will decide each year which project to support, and it is also recognition of the tireless and dedicated way in which Mrs Liefers - one of the first patient to be treated - has helped us to discover the positive effects that KFH Energy can have in the lives of people who had polio as children.
Note to Editors:
KFH is a young healthcare company , developing its own pipeline of
proprietary products. It utilizes a technology platform called BEST
(Bio-Electric Stimulation Therapy), from which unique products are
developed. These products alleviate specific symptoms a
|SOURCE Kingfisher Healthcare|
Copyright©2007 PR Newswire.
All rights reserved